Rubius Therapeutics, Inc. Contracts & Agreements
32 Contracts & Agreements
- Business Finance (11 contracts)
- Human Resources (14)
- Intellectual Property (1)
- Real Estate (2)
- Uncategorized (4)
- Plan of Dissolution of Rubius Therapeutics, Inc (Filed With SEC on February 22, 2023)
- Agreement for Termination of Lease, dated December 12, 2022, by and between Rubius Therapeutics, Inc. and ARE-MA Region No. 58, LLC (Filed With SEC on December 14, 2022)
- Purchase and Sale Agreement, dated December 6, 2022, by and between Rubius Therapeutics, Inc. and DIV Acquisition V, LLC (Filed With SEC on December 12, 2022)
- Non-Employee Director Compensation Policy dated February 24, 2021 (Filed With SEC on February 25, 2022)
- Second Amendment to Loan and Security Agreement between Rubius Therapeutics, Inc. and SLR Investment Corp. (formerly Solar Capital Ltd.) dated June 22, 2021 (Filed With SEC on August 9, 2021)
- Employment Agreement dated July 26, 2021 between Rubius Therapeutics, Inc. and Dannielle Appelhans (Filed With SEC on July 29, 2021)
- Underwriting Agreement, dated March 16, 2021, among Rubius Therapeutics, Inc., J.P. Morgan Securities LLC, Jefferies LLC and Guggenheim Securities, LLC (Filed With SEC on March 18, 2021)
- Employment Agreement dated September 23, 2020 between Rubius Therapeutics, Inc. and Jose Carmona (Filed With SEC on September 28, 2020)
- Separation Agreement between Rubius Therapeutics, Inc. and Andrew M. Oh, dated June 29, 2020 (Filed With SEC on August 10, 2020)
- Employment Agreement between Rubius Therapeutics, Inc. and Christina Coughlin, dated December 20, 2019 (Filed With SEC on May 11, 2020)
- Employment Agreement between Rubius Therapeutics, Inc. and Laurence Turka, dated January 4, 2020 (Filed With SEC on May 11, 2020)
- Description of Registrants Securities (Filed With SEC on March 12, 2020)
- Employment Agreement between Rubius Therapeutics, Inc. and Maiken Keson-Brookes, dated October 7, 2019 (Filed With SEC on March 12, 2020)
- First Amendment to the Loan and Security Agreement dated as of September 16, 2019 between Rubius Therapeutics, Inc. and Solar Capital Ltd (Filed With SEC on November 14, 2019)
- Letter Agreement between Rubius Therapeutics, Inc. and Torben Straight Nissen, Ph.D. dated May 14, 2019 (Filed With SEC on August 13, 2019)
- First Amendment to Lease Agreement between Rubius Therapeutics, Inc. and ARE-MA Region No. 58 LLC, dated November 8, 2018 (Filed With SEC on March 28, 2019)
- Second Amendment to the Exclusive Patent License Agreement between the Registrant and the Whitehead Institute for Biomedical Research, dated July 25, 2018 (Filed With SEC on March 28, 2019)
- Loan and Security Agreement between Rubius Therapeutics, Inc. and Solar Capital Ltd. dated December 21, 2018 (Filed With SEC on December 21, 2018)
- Purchase and Sale Agreement between the Registrant and Alexion Pharmaceuticals, Inc., dated July 23, 2018 (Filed With SEC on July 25, 2018)
- Form of Underwriting Agreement (Filed With SEC on July 9, 2018)
- 2018 Stock Option and Incentive Plan, and form of award agreements thereunder (Filed With SEC on July 9, 2018)
- 2018 Employee Stock Purchase Plan (Filed With SEC on July 9, 2018)
- Employment Agreement between the Registrant and Pablo J. Cagnoni, M.D., dated July 2, 2018 (Filed With SEC on July 9, 2018)
- Employment Agreement between the Registrant and Torben Straight Nissen, Ph.D., dated July 2, 2018 (Filed With SEC on July 9, 2018)
- Employment Agreement between the Registrant and Andrew M. Oh, dated June 29, 2018 (Filed With SEC on July 9, 2018)
- Employment Agreement between the Registrant and Christopher L. Carpenter, M.D., Ph.D., dated June 29, 2018 (Filed With SEC on July 9, 2018)
- Second Amended and Restated Investors' Rights Agreement among the Registrant and certain of its stockholders, dated February 23, 2018 (Filed With SEC on June 22, 2018)
- Amended and Restated Warrant to Purchase Stock, dated May 19, 2017, issued by the Registrant to PacWest Bancorp (Filed With SEC on June 22, 2018)
- Amended and Restated Second Warrant to Purchase Stock, dated September 13, 2017, issued by the Registrant to PacWest Bancorp (Filed With SEC on June 22, 2018)
- Amended and Restated 2014 Stock Incentive Plan, and form of award agreements thereunder (Filed With SEC on June 22, 2018)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on June 22, 2018)
- Second Amended and Restated Chairman Agreement between the Registrant and David R. Epstein (Filed With SEC on June 22, 2018)
